---
title: Imaging Flow Cytometry and Convolutional Neural Network-Based Classification
  Enable Discrimination of Hematopoietic and Leukemic Stem Cells in Acute Myeloid
  Leukemia
date: '2024-06-27'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38928171/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1byXLWG-5Hn0_qdLgZYpDfLA2UWGhGNgZGereuo1rJN2aoAQXP&fc=20220814223158&ff=20240627181857&v=2.18.0.post9+e462414
source: (deep learning) AND ((leukemia) OR (lymphoma))
description: 'Acute myeloid leukemia (AML) is a heterogenous blood cancer with a dismal
  prognosis. It emanates from leukemic stem cells (LSCs) arising from the genetic
  transformation of hematopoietic stem cells (HSCs). LSCs hold prognostic value, but
  their molecular and immunophenotypic heterogeneity poses challenges: there is no
  single marker for identifying all LSCs across AML samples. We hypothesized that
  imaging flow cytometry (IFC) paired with artificial intelligence-driven image analysis
  could ...'
disable_comments: true
---
Acute myeloid leukemia (AML) is a heterogenous blood cancer with a dismal prognosis. It emanates from leukemic stem cells (LSCs) arising from the genetic transformation of hematopoietic stem cells (HSCs). LSCs hold prognostic value, but their molecular and immunophenotypic heterogeneity poses challenges: there is no single marker for identifying all LSCs across AML samples. We hypothesized that imaging flow cytometry (IFC) paired with artificial intelligence-driven image analysis could ...